Cancertope

In silico Platform for designing genome-based
Personalized immunotherapy or Vaccine against Cancer

Predicted Immune Epitope Results


The result page of search shows exclusive peptide/epitopes generated due to mutation [Neoepitope], the tissue of origin [Tissue], position of peptide in protein [Position], number of mismatches counted by aligning mutated and normal protein sequence [Num Mismatch, percentage of cell lines with this peptide over total number of cell lines [Promiscuity %]. The immune information include CTL epitopes (Yes/No), MHC I binders, MHC II binders (both given as number of alleles) and B cell epitopes (Yes/No). For more information, please click HERE


NeoepitopesVYFKILYLL        Click here to BLAST against human proteome
CTL Epitope
(CTLPred)
Y
HLA I Alleles
(ProPred I)
HLA-A2.1, HLA-A24, HLA-B*3701, HLA-B*3801, HLA-B*3901, HLA-B*3902, HLA-B*51, HLA-B*5301, HLA-B*5401, HLA-Cw*0401, HLA-Cw*0602, HLA-Cw*0702, MHC-Kb, MHC-Kd14
HLA I Alleles
(nHLAPred)
HLA-Cw*0401, H2-Db, H2-Dd, H2-Kb, H2-Kd, H2-Ld, HLA-G, H-2Qa, Mamu-A*019
HLA II Alleles
(PrePred)
DRB1_0801, DRB1_0802, DRB1_0804, DRB1_0806, DRB1_0813, DRB1_08176
B_Cell_Epitope
(ABCPred)
N

CANCERTOPE    |     Raghava's Group    |     IMTECH    |     CSIR    |     CRDD    |     GPSR Package